Maurice Alan Brookhart
Professor in Population Health Sciences
M. Alan Brookhart, Ph.D. is a Professor in the Department of Population Health Sciences at Duke University. He is also an Adjunct Professor at UNC Chapel Hill and an Honorary Professor of Clinical Epidemiology at Aarhus University, Denmark. Alan did his doctoral training in biostatistics at UC Berkeley and was on faculty at Harvard Medical School and UNC Chapel Hill prior to joining the faculty at Duke.
Alan has spent his career developing epidemiologic and statistical methods for improving learning from real-world healthcare data. Substantively, his research has focused on understanding the effects of treatments and policies in complex and vulnerable patient populations, such as those with end-stage renal disease. He has taught courses and workshops in pharmacoepidemiology, causal inference, epidemiologic methods, cluster-randomized trials, data visualization, and machine learning. He is a member of many expert panels for industry, academia, not-for-profit organizations, and government.
In addition to his academic work, Alan co-founded two start-up companies: RxAnte, Inc, which uses predictive analytics to target adherence improvement interventions to high-risk patients, and NoviSci, Inc, a healthcare data sciences company that builds tools to facilitate learning and visualization in complex, real-world data.
Areas of Expertise: epidemiology, observational study design, causal inference, predictive models, and data visualization
Current Appointments & Affiliations
- Professor in Population Health Sciences, Population Health Sciences, Basic Science Departments 2021
Contact Information
- Background
-
Education, Training, & Certifications
- Ph.D., University of California - Berkeley 2002
- M.A., University of California - Berkeley 1996
- A.B., University of North Carolina - Chapel Hill 1990
-
Previous Appointments & Affiliations
- Professor in Population Health Sciences, Population Health Sciences, Basic Science Departments 2020
- Instructor in the Department of Population Health Sciences, Population Health Sciences, Basic Science Departments 2019 - 2020
- Research
-
Selected Grants
- Advancing the Measurement and Classification of Lower Urinary Tract Dysfunction awarded by National Institutes of Health 2012 - 2024
- QT prolonging medications and sudden cardiac death among individuals on hemodialysis awarded by University of North Carolina - Chapel Hill 2020 - 2024
- National Study of Community-Acquired Acute Kidney Injury Epidemiology and Outcomes awarded by National Institutes of Health 2019 - 2023
- ABCs of North Carolina Plan A awarded by NC Department of Public Instruction 2021 - 2022
-
External Relationships
- Accompany Health
- American Academy of Allergy, Asthma & Immunology
- Amgen, Inc.
- Brigham and Women's Hospital (BWH)
- Gilead Sciences, Inc.
- Kite pharmaceuticals (Gilead)
- National Institute of Health (NIH)
- Pharmacosmos
- Target RWE, Inc
- Vertex Pharmaceuticals Inc.
- Publications & Artistic Works
-
Selected Publications
-
Academic Articles
-
McGrath, Leah J., Carrie Nielson, Bradley Saul, Alexander Breskin, Ying Yu, Sia K. Nicolaisen, Karynsa Kilpatrick, et al. “Lessons Learned Using Real-World Data to Emulate Randomized Trials: A Case Study of Treatment Effectiveness for Newly Diagnosed Immune Thrombocytopenia.” Clin Pharmacol Ther 110, no. 6 (December 2021): 1570–78. https://doi.org/10.1002/cpt.2399.Full Text Link to Item
-
Zimmerman, Kanecia O., M Alan Brookhart, Ibukunoluwa C. Kalu, Angelique E. Boutzoukas, Kathleen A. McGann, Michael J. Smith, Gabriela M. Maradiaga Panayotti, et al. “Community SARS-CoV-2 Surge and Within-School Transmission.” Pediatrics 148, no. 4 (October 2021). https://doi.org/10.1542/peds.2021-052686.Full Text Link to Item
-
Butler, Anne M., Alexander Breskin, John M. Sahrmann, and M Alan Brookhart. “Estimating the Effectiveness of Rotavirus Vaccine Schedules.” Epidemiology 32, no. 4 (July 1, 2021): 598–606. https://doi.org/10.1097/EDE.0000000000001363.Full Text Link to Item
-
Snell Taylor, Sara J., Carrie M. Nielson, Alexander Breskin, Bradley Saul, Ying Yu, Naufil Alam, Melissa Eisen, et al. “Effectiveness and Safety of Romiplostim Among Patients with Newly Diagnosed, Persistent and Chronic Immune Thrombocytopenia in European Clinical Practice.” Adv Ther 38, no. 5 (May 2021): 2673–88. https://doi.org/10.1007/s12325-021-01727-5.Full Text Link to Item
-
Zimmerman, Kanecia O., Ibukunoluwa C. Akinboyo, M Alan Brookhart, Angelique E. Boutzoukas, Kathleen A. McGann, Michael J. Smith, Gabriela Maradiaga Panayotti, et al. “Incidence and Secondary Transmission of SARS-CoV-2 Infections in Schools.” Pediatrics 147, no. 4 (April 2021). https://doi.org/10.1542/peds.2020-048090.Full Text Link to Item
-
Gershon, Andrea S., Peter K. Lindenauer, Kevin C. Wilson, Louise Rose, Allan J. Walkey, Mohsen Sadatsafavi, Kevin J. Anstrom, et al. “Informing Healthcare Decisions with Observational Research Assessing Causal Effect. An Official American Thoracic Society Research Statement.” Am J Respir Crit Care Med 203, no. 1 (January 1, 2021): 14–23. https://doi.org/10.1164/rccm.202010-3943ST.Full Text Link to Item
-
Yeob Choi, Byeong, Jason P. Fine, and M. Alan Brookhart. “Bias testing, bias correction, and confounder selection using an instrumental variable model.” Stat Med 39, no. 29 (December 20, 2020): 4386–4404. https://doi.org/10.1002/sim.8730.Full Text Link to Item
-
Kaviani, Pardiss, Suzanne N. Landi, Aaron McKethan, M Alan Brookhart, and Leah J. McGrath. “Who are we missing? Underrepresentation of data sources used for pharmacoepidemiology research in the United States.” Pharmacoepidemiol Drug Saf 29, no. 11 (November 2020): 1494–98. https://doi.org/10.1002/pds.5087.Full Text Link to Item
-
McGrath, Leah J., Leslie Spangler, Jeffrey R. Curtis, Vera Ehrenstein, Henrik T. Sørensen, Bradley Saul, Sara N. Levintow, Diane Reams, Brian D. Bradbury, and M Alan Brookhart. “Using negative control outcomes to assess the comparability of treatment groups among women with osteoporosis in the United States.” Pharmacoepidemiol Drug Saf 29, no. 8 (August 2020): 854–63. https://doi.org/10.1002/pds.5037.Full Text Link to Item
-
Xi, Yuzhi, Abhijit V. Kshirsagar, Timothy J. Wade, David B. Richardson, M Alan Brookhart, Lauren Wyatt, and Ana G. Rappold. “Mortality in US Hemodialysis Patients Following Exposure to Wildfire Smoke.” J Am Soc Nephrol 31, no. 8 (August 2020): 1824–35. https://doi.org/10.1681/ASN.2019101066.Full Text Link to Item
-
Kshirsagar, Abhijit V., Xiaojuan Li, Bruce M. Robinson, and M Alan Brookhart. “At the Crossroads for Intravenous Iron Dosing.” J Am Soc Nephrol 31, no. 7 (July 2020): 1653–54. https://doi.org/10.1681/ASN.2020040540.Full Text Link to Item
-
Krishnamoorthy, Vijay, Alan R. Ellis, Duncan J. McLean, Mihaela S. Stefan, Brian H. Nathanson, Julien Cobert, Peter K. Lindenauer, M Alan Brookhart, Tetsu Ohnuma, and Karthik Raghunathan. “Bleeding After Musculoskeletal Surgery in Hospitals That Switched From Hydroxyethyl Starch to Albumin Following a Food and Drug Administration Warning.” Anesth Analg, June 10, 2020. https://doi.org/10.1213/ANE.0000000000004942.Full Text Link to Item
-
Lousdal, Mette Lise, Timothy L. Lash, W Dana Flanders, M Alan Brookhart, Ivar Sønbø Kristiansen, Mette Kalager, and Henrik Støvring. “Negative controls to detect uncontrolled confounding in observational studies of mammographic screening comparing participants and non-participants.” Int J Epidemiol 49, no. 3 (June 1, 2020): 1032–42. https://doi.org/10.1093/ije/dyaa029.Full Text Link to Item
-
Rymer, Jennifer A., Katherine E. Mues, Keri L. Monda, Emily W. Bratton, Heidi S. Wirtz, Ted Okerson, Robert A. Overman, M Alan Brookhart, Paul Muntner, and Tracy Y. Wang. “Use of Low-Density Lipoprotein-Lowering Therapies Before and After PCSK9 Inhibitor Initiation.” J Am Heart Assoc 9, no. 9 (May 5, 2020): e014347. https://doi.org/10.1161/JAHA.119.014347.Full Text Link to Item
-
Levintow, Sara N., Stephanie R. Reading, Bradley C. Saul, Ying Yu, Diane Reams, Leah J. McGrath, Kiran Philip, Paul J. Dluzniewski, and M Alan Brookhart. “Lipid Testing Trends in the US Before and After the Release of the 2013 Cholesterol Treatment Guidelines.” Clin Epidemiol 12 (2020): 835–45. https://doi.org/10.2147/CLEP.S259757.Full Text Link to Item
-
Chen, Qi, Hung-Lun Hsia, Robert Overman, William Bryan, Marc Pepin, Edward R. Mariano, Seshadri C. Mudumbai, et al. “Impact of an Opioid Safety Initiative on Patients Undergoing Total Knee Arthroplasty: A Time Series Analysis.” Anesthesiology 131, no. 2 (August 2019): 369–80. https://doi.org/10.1097/ALN.0000000000002771.Full Text Link to Item
-
Maciejewski, Matthew L., and M Alan Brookhart. “Using Instrumental Variables to Address Bias From Unobserved Confounders.” Jama 321, no. 21 (June 4, 2019): 2124–25. https://doi.org/10.1001/jama.2019.5646.Full Text Link to Item
-
Cole, Stephen R., Michael G. Hudgens, Jessie K. Edwards, M Alan Brookhart, David B. Richardson, Daniel Westreich, and Adaora A. Adimora. “Nonparametric Bounds for the Risk Function.” Am J Epidemiol 188, no. 4 (April 1, 2019): 632–36. https://doi.org/10.1093/aje/kwz013.Full Text Link to Item
-
Bushnell, Greta A., Stacie B. Dusetzina, Scott N. Compton, Bradley N. Gaynes, M Alan Brookhart, and Til Stürmer. “Psychotherapy Claims Surrounding Pharmacotherapy Initiation in Children and Adolescents with Anxiety Disorders.” J Child Adolesc Psychopharmacol 29, no. 2 (March 2019): 100–106. https://doi.org/10.1089/cap.2018.0108.Full Text Link to Item
-
Bushnell, Greta A., Bradley N. Gaynes, Scott N. Compton, Stacie B. Dusetzina, M Alan Brookhart, and Til Stürmer. “Incidence of mental health hospitalizations, treated self-harm, and emergency room visits following new anxiety disorder diagnoses in privately insured U.S. children.” Depress Anxiety 36, no. 2 (February 2019): 179–89. https://doi.org/10.1002/da.22849.Full Text Link to Item
-
McGrath, Leah J., Rohini K. Hernandez, Robert Overman, Diane Reams, Alexander Liede, M Alan Brookhart, and Elizabeth O’Donnell. “Initiation and interruption in intravenous bisphosphonate therapy among patients with multiple myeloma in the United States.” Cancer Med 8, no. 1 (January 2019): 374–82. https://doi.org/10.1002/cam4.1869.Full Text Link to Item
-
Weinstock, Martin A., Robert A. Lew, Fiona M. Shaw, and Fiona M. Veterans Affairs Keratinocyte Carcinoma Chemoprevention Trial (VAKCC) Group. “Problematic End Points in a Trial of Topical Fluorouracil, 5%, for Chemoprevention of Keratinocyte Carcinoma-Reply.” Jama Dermatol 154, no. 7 (July 1, 2018): 851–52. https://doi.org/10.1001/jamadermatol.2018.1230.Full Text Link to Item
-
Bushnell, Greta A., M Alan Brookhart, Bradley N. Gaynes, Scott N. Compton, Stacie B. Dusetzina, and Til Stürmer. “Examining Parental Medication Adherence as a Predictor of Child Medication Adherence in Pediatric Anxiety Disorders.” Med Care 56, no. 6 (June 2018): 510–19. https://doi.org/10.1097/MLR.0000000000000911.Full Text Link to Item
-
Bushnell, Greta A., Scott N. Compton, Stacie B. Dusetzina, Bradley N. Gaynes, M Alan Brookhart, John T. Walkup, Moira A. Rynn, and Til Stürmer. “Treating Pediatric Anxiety: Initial Use of SSRIs and Other Antianxiety Prescription Medications.” J Clin Psychiatry 79, no. 1 (2018). https://doi.org/10.4088/JCP.16m11415.Full Text Link to Item
-
McGrath, Leah J., Robert A. Overman, Diane Reams, Karynsa Cetin, Alexander Liede, Steven A. Narod, M Alan Brookhart, and Rohini K. Hernandez. “Use of bone-modifying agents among breast cancer patients with bone metastasis: evidence from oncology practices in the US.” Clin Epidemiol 10 (2018): 1349–58. https://doi.org/10.2147/CLEP.S175063.Full Text Link to Item
-
Winkelmayer, Wolfgang C., Benjamin A. Goldstein, Aya A. Mitani, Victoria Y. Ding, Medha Airy, Sreedhar Mandayam, Tara I. Chang, M Alan Brookhart, and Steven Fishbane. “Safety of Intravenous Iron in Hemodialysis: Longer-term Comparisons of Iron Sucrose Versus Sodium Ferric Gluconate Complex.” Am J Kidney Dis 69, no. 6 (June 2017): 771–79. https://doi.org/10.1053/j.ajkd.2016.10.031.Full Text Link to Item
-
Siegel, Julia A., Mary-Margaret Chren, Martin A. Weinstock, and Martin A. Department of Veterans Affairs Keratinocyte Carcinoma Chemoprevention Trial Group. “Correlates of skin-related quality of life (QoL) in those with multiple keratinocyte carcinomas (KCs): A cross-sectional study.” J Am Acad Dermatol 75, no. 3 (September 2016): 639–42. https://doi.org/10.1016/j.jaad.2016.05.008.Full Text Link to Item
-
Airy, Medha, Sreedhar Mandayam, Aya A. Mitani, Tara I. Chang, Victoria Y. Ding, M Alan Brookhart, Benjamin A. Goldstein, and Wolfgang C. Winkelmayer. “Comparative outcomes of predominant facility-level use of ferumoxytol versus other intravenous iron formulations in incident hemodialysis patients.” Nephrol Dial Transplant 30, no. 12 (December 2015): 2068–75. https://doi.org/10.1093/ndt/gfv305.Full Text Link to Item
-
Raghunathan, Karthik, Anthony Bonavia, Brian H. Nathanson, Christopher A. Beadles, Andrew D. Shaw, M Alan Brookhart, Timothy E. Miller, and Peter K. Lindenauer. “Association between Initial Fluid Choice and Subsequent In-hospital Mortality during the Resuscitation of Adults with Septic Shock.” Anesthesiology 123, no. 6 (December 2015): 1385–93. https://doi.org/10.1097/ALN.0000000000000861.Full Text Open Access Copy Link to Item
-
Dusetzina, Stacie B., M Alan Brookhart, and Matthew L. Maciejewski. “Control Outcomes and Exposures for Improving Internal Validity of Nonrandomized Studies.” Health Serv Res 50, no. 5 (October 2015): 1432–51. https://doi.org/10.1111/1475-6773.12279.Full Text Link to Item
-
Winkelmayer, Wolfgang C., Tara I. Chang, Aya A. Mitani, Emilee R. Wilhelm-Leen, Victoria Ding, Glenn M. Chertow, M Alan Brookhart, and Benjamin A. Goldstein. “Longer-term outcomes of darbepoetin alfa versus epoetin alfa in patients with ESRD initiating hemodialysis: a quasi-experimental cohort study.” Am J Kidney Dis 66, no. 1 (July 2015): 106–13. https://doi.org/10.1053/j.ajkd.2015.02.339.Full Text Link to Item
-
Camelo Castillo, Wendy, Kim Boggess, Til Stürmer, M Alan Brookhart, Daniel K. Benjamin, and Michele Jonsson Funk. “Association of Adverse Pregnancy Outcomes With Glyburide vs Insulin in Women With Gestational Diabetes.” Jama Pediatr 169, no. 5 (May 2015): 452–58. https://doi.org/10.1001/jamapediatrics.2015.74.Full Text Link to Item
-
Camelo Castillo, Wendy, Kim Boggess, Til Stürmer, M Alan Brookhart, Daniel K. Benjamin, and Michele Jonsson Funk. “Trends in glyburide compared with insulin use for gestational diabetes treatment in the United States, 2000-2011.” Obstet Gynecol 123, no. 6 (June 2014): 1177–84. https://doi.org/10.1097/AOG.0000000000000285.Full Text Link to Item
-
Beadles, Christopher A., Kristen Hassmiller Lich, Anthony J. Viera, Sandra B. Greene, M Alan Brookhart, and Morris Weinberger. “Patient-centered medical homes and oral anticoagulation therapy initiation.” Med Care Res Rev 71, no. 2 (April 2014): 174–91. https://doi.org/10.1177/1077558713510563.Full Text Link to Item
-
Beadles, Christopher A., Kristen Hassmiller Lich, Anthony J. Viera, Sandra B. Greene, M Alan Brookhart, and Morris Weinberger. “A non-experimental study of oral anticoagulation therapy initiation before and after national patient safety goals.” Bmj Open 4, no. 2 (February 12, 2014): e003960. https://doi.org/10.1136/bmjopen-2013-003960.Full Text Link to Item
-
Schoenfisch, Ashley L., Hester J. Lipscomb, Stephen W. Marshall, Carri Casteel, David B. Richardson, M Alan Brookhart, and Wilfrid Cameron. “Declining rates of work-related overexertion back injuries among union drywall installers in Washington State, 1989-2008: Improved work safety or shifting of care?” Am J Ind Med 57, no. 2 (February 2014): 184–94. https://doi.org/10.1002/ajim.22240.Full Text Link to Item
-
Le, Hoa V., Charles Poole, M Alan Brookhart, Victor J. Schoenbach, Kathleen J. Beach, J Bradley Layton, and Til Stürmer. “Effects of aggregation of drug and diagnostic codes on the performance of the high-dimensional propensity score algorithm: an empirical example.” Bmc Med Res Methodol 13 (November 19, 2013): 142. https://doi.org/10.1186/1471-2288-13-142.Full Text Link to Item
-
Castillo, Wendy Camelo, Kim Boggess, Til Sturmer, M Alan Brookhart, and Daniel K. Benjamin. “Use of Glyburide vs. Insulin for Treatment of Gestational Diabetes in the US, 2000-2010.” Pharmacoepidemiology and Drug Safety 22 (October 1, 2013): 145–145.Link to Item
-
Platt, Robert W., M Alan Brookhart, Stephen R. Cole, Daniel Westreich, and Enrique F. Schisterman. “Reply to taguri and matsuyama.” Stat Med 32, no. 20 (September 10, 2013): 3592–93. https://doi.org/10.1002/sim.5805.Full Text Link to Item
-
Platt, Robert W., M Alan Brookhart, Stephen R. Cole, Daniel Westreich, and Enrique F. Schisterman. “An information criterion for marginal structural models.” Stat Med 32, no. 8 (April 15, 2013): 1383–93. https://doi.org/10.1002/sim.5599.Full Text Link to Item
-
Balasubramanian, Akhila, M Alan Brookhart, Vamshidar Goli, and Cathy W. Critchlow. “Discontinuation and reinitiation patterns of osteoporosis treatment among commercially insured postmenopausal women.” Int J Gen Med 6 (2013): 839–48. https://doi.org/10.2147/IJGM.S36944.Full Text Link to Item
-
Liu, Wei, M Alan Brookhart, Sebastian Schneeweiss, Xiaojuan Mi, and Soko Setoguchi. “Implications of M bias in epidemiologic studies: a simulation study.” Am J Epidemiol 176, no. 10 (November 15, 2012): 938–48. https://doi.org/10.1093/aje/kws165.Full Text Link to Item
-
Stedman, Margaret R., David R. Gagnon, Robert A. Lew, Sin-Ho Jung, Elena Losina, and M Alan Brookhart. “A SAS macro for a clustered logrank test.” Comput Methods Programs Biomed 104, no. 2 (November 2011): 266–70. https://doi.org/10.1016/j.cmpb.2011.02.001.Full Text Link to Item
-
Funk, Michele Jonsson, Daniel Westreich, Chris Wiesen, Til Stürmer, M Alan Brookhart, and Marie Davidian. “Doubly robust estimation of causal effects.” Am J Epidemiol 173, no. 7 (April 1, 2011): 761–67. https://doi.org/10.1093/aje/kwq439.Full Text Link to Item
-
Westreich, Daniel, Stephen R. Cole, Michele Jonsson Funk, M Alan Brookhart, and Til Stürmer. “The role of the c-statistic in variable selection for propensity score models.” Pharmacoepidemiol Drug Saf 20, no. 3 (March 2011): 317–20. https://doi.org/10.1002/pds.2074.Full Text Link to Item
-
Winkelmayer, Wolfgang C., Amanda R. Patrick, Jun Liu, M Alan Brookhart, and Soko Setoguchi. “The increasing prevalence of atrial fibrillation among hemodialysis patients.” J Am Soc Nephrol 22, no. 2 (February 2011): 349–57. https://doi.org/10.1681/ASN.2010050459.Full Text Link to Item
-
-
Conference Papers
-
DiPrete, Bethany, Cynthia J. Girman, Panagiotis Mavros, Alexander Breskin, and M Alan Brookhart. “Characterizing imbalance in the tails of the propensity score distribution.” In Pharmacoepidemiology and Drug Safety, 30:99–99, 2021.Link to Item
-
Landi, Suzanne N., Min Kim, Sara Snell Taylor, Catie Wiener, Michele McDermott, Cynthia Deignan, Jay Lin, et al. “Visualization methods to examine treatment patterns in pharmacoepidemiology: An example using osteoporosis medications.” In Pharmacoepidemiology and Drug Safety, 30:397–397, 2021.Link to Item
-
Latour, Chase D., Leah J. McGrath, Alexander Breskin, Ying Yu, and M Alan Brookhart. “Controlling for differential regression to the mean using summary measures of pre-treatment laboratory values in propensity scores.” In Pharmacoepidemiology and Drug Safety, 30:70–70, 2021.Link to Item
-
Levintow, Sara, Kate Orroth, Alexander Breskin, Paul Dluzniewski, Andrew Park, and M Alan Brookhart. “Use of negative control outcomes to detect mismeasured confounders in administrative data.” In Pharmacoepidemiology and Drug Safety, 30:385–86, 2021.Link to Item
-
Mayer, Sophie E., Leah J. McGrath, Min Kim, Michele McDermott, and M Alan Brookhart. “Prevalence of osteoporosis and its treatment among women >= 50 in NHANES: 1999-2018.” In Pharmacoepidemiology and Drug Safety, 30:28–28, 2021.Link to Item
-
McGrath, Leah J., Min Kim, David Pritchard, Ying Yu, Peter Samai, Akhila Balasubramanian, Jay Lin, et al. “Using negative control outcomes to assess the comparability of treatment groups among postmenopausal women switching osteoporosis therapy.” In Pharmacoepidemiology and Drug Safety, 30:389–90, 2021.Link to Item
-
Orroth, Kate K., Sara N. Levintow, Alexander Breskin, Paul Dluzniewski, Andrew S. Park, and M Alan Brookhart. “USE OF NEGATIVE CONTROL OUTCOMES TO ASSESS THE COMPARABILITY OF TREATMENTS FOR HYPERCHOLESTEROLEMIA.” In Journal of the American College of Cardiology, 77:1496–1496, 2021.Link to Item
-
Breskin, Alexander, Anne M. Butler, John Sahrmann, and M Alan Brookhart. “Estimating vaccine effects: A comparison of causal methods.” In Pharmacoepidemiology and Drug Safety, 29:361–62, 2020.Link to Item
-
Landi, Suzanne, Pardiss Kaviani, Aaron McKethan, M Alan Brookhart, and Leah McGrath. “Who are we missing?: Underrepresentation of data sources used for pharmacoepidemiology research in the United States.” In Pharmacoepidemiology and Drug Safety, 29:427–28, 2020.Link to Item
-
Levintow, Sara N., Catie Wiener, Kate K. Orroth, Karminder Gill, Andrew Mullard, M Alan Brookhart, and Leah J. McGrath. “History of lipid lowering therapy use among adults initiating treatment with proprotein convertase subtilisin/kexin type 9 antibody inhibitors in the United States, 2015-2019.” In Pharmacoepidemiology and Drug Safety, 29:55–55, 2020.Link to Item
-
McGrath, Leah J., Alexander Breskin, Bradley Saul, Ying Yu, Michael Kelsh, Kara Kilpatrick, Carrie M. Nielson, and M Alan Brookhart. “Comparing inverse probability of treatment and standardized mortality ratio weights in a small sample setting.” In Pharmacoepidemiology and Drug Safety, 29:363–64, 2020.Link to Item
-
McGrath, Leah J., Karynsa Kilpatrick, Robert A. Overman, Diane Reams, Anjali Sharma, Ivy Altomare, Jeffrey Wasser, and M Alan Brookhart. “Treatment Patterns Among Adults with Primary Immune Thrombocytopenia Diagnosed in Hematology Clinics in the United States.” In Clin Epidemiol, 12:435–45, 2020. https://doi.org/10.2147/CLEP.S229266.Full Text Link to Item
-
Rassen, Jeremy A., Shirley V. Wang, Nicolle M. Gatto, and M Alan Brookhart. “Visual space: Using visualization in pharmacoepidemiology to design and disseminate valid real-world evidence in a structured framework.” In Pharmacoepidemiology and Drug Safety, 29:432–432, 2020.Link to Item
-
Wiener, Catie, Sara N. Levintow, Kate K. Orroth, Karminder Gill, Andrew Mullard, Leah J. McGrath, and M Alan Brookhart. “Real world treatment patterns following the initiation of proprotein convertase subtilisin/kexin type 9 antibody inhibitors among adults in the United States, 2015-2019.” In Pharmacoepidemiology and Drug Safety, 29:55–56, 2020.Link to Item
-
McGrath, Leah J., Leslie Spangler, Jeffrey R. Curtis, Vera Ehrenstein, Henrik Toft Sorensen, Bradley Saul, Sara Levintow, M Alan Brookhart, and Brian D. Bradbury. “Using Negative Control Outcomes to Assess the Comparability of Osteoporosis Treatment Groups.” In Pharmacoepidemiology and Drug Safety, 28:27–28. WILEY, 2019.Link to Item
-
Saul, Bradley, Ryan D. Kilpatrick, Leah J. McGrath, Diane Reams, Lani Wegrzyn, Stephanie E. Chiuve, and M Alan Brookhart. “Performance of machine learning algorithms for hysterectomy risk prediction among women with endometriosis in the United States.” In Pharmacoepidemiology and Drug Safety, 28:228–29. WILEY, 2019.Link to Item
-
Mclean, Duncan J., Vijay Krishnamoorthy, Alan Ellis, Mihaela Stefan, Brian Nathanson, Julien Cobert, Peter Lindenauer, M. A. Brookhart, and Karthik Raghunathan. “ASSOCIATION OF COLLOID CHOICE AND BLEEDING FOLLOWING MUSCULOSKELETAL SURGERY: A RETROSPECTIVE COHORT STUDY AND NATURAL EXPERIMENT.” In Anesthesia and Analgesia, 128:821–24, 2019.Link to Item
-
Cetin, Karynsa, Leah J. McGrath, Robert Overman, Diane Reams, Anjali Sharma, M Alan Brookhart, Ivy Altomare, and Jeffrey S. Wasser. “Treatment Patterns Among Adults with Newly Diagnosed Primary Immune Thrombocytopenia in the United States.” In Blood, 132:497–497. American Society of Hematology, 2018. https://doi.org/10.1182/blood-2018-99-117252.Full Text
-
McGrath, Leah, Karynsa Cetin, Robert Overman, Diane Reams, Anjali Sharma, Ivy Altomare, M Alan Brookhart, and Jeffrey Wasser. “REAL-WORLD PATTERNS OF ROMIPLOSTIM TREATMENT IN ADULTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA IN THE UNITED STATES.” In American Journal of Hematology, 93:E45–46. WILEY, 2018.Link to Item
-
Thai, Sydney T., Wayne D. Rosamond, Anthony J. Viera, Patricia P. Chang, Salim S. Virani, M Alan Brookhart, Montika Bush, Laura R. Loehr, June Stevens, and Anna Kucharska-Newton. “Predictors of outpatient cardiac rehabilitation referral among hospitalized heart failure patients: The Atherosclerosis Risk in Communities (ARIC) study.” In Pharmacoepidemiology and Drug Safety, 27:82–82. WILEY, 2018.Link to Item
-
Levintow, Sara, Leah McGrath, and M Alan Brookhart. “Estimating cumulative risk in the presence of competing events and dependent censoring in pharmacoepidemiology studies.” In Pharmacoepidemiology and Drug Safety, 27:7–7. WILEY, 2018.Link to Item
-
McGrath, Leah J., Rohini K. Hernandez, Ying Yu, Robert A. Overman, Diane Reams, Alexander Liede, and M Alan Brookhart. “Agreement between electronic health records and administrative claims data for patients with multiple myeloma.” In Pharmacoepidemiology and Drug Safety, 27:86–86. WILEY, 2018.Link to Item
-
Bushnell, Greta A., M Alan Brookhart, Bradley N. Gaynes, Scott N. Compton, Stacie B. Dusetzina, and Til Sturmer. “Examining Parental Adherence as a Predictor of Child SSRI Adherence in Pediatric Anxiety.” In Pharmacoepidemiology and Drug Safety, 26:240–41. WILEY, 2017.Link to Item
-
Liede, Alexander, Anne M. Butler, Karynsa Cetin, Rohini K. Hernandez, Robert Overman, JungIn Kim, B Diane Reams, Bradford Richard Hirsch, Amy Pickar Abernethy, and M Alan Brookhart. “Initiation and adherence with bone-targeting agents in US men with bone metastases from prostate cancer.” In Journal of Clinical Oncology, 34:e13083–e13083. American Society of Clinical Oncology (ASCO), 2016. https://doi.org/10.1200/jco.2016.34.15_suppl.e13083.Full Text
-
Airy, Medha, Sreedhar Mandayam, Aya A. Mitani, Tara I. Chang, M Alan Brookhart, Benjamin A. Goldstein, and Wolfgang C. Winkelmayer. “Outcomes of Facility-level Use of Ferumoxytol versus Other Intravenous Iron Formulations in Incident Hemodialysis Patients.” In Pharmacoepidemiology and Drug Safety, 24:341–42. WILEY-BLACKWELL, 2015.Link to Item
-
Pomerantz, Hyemin, Daniel Hogan, David Eilers, Susan M. Swetter, Suephy C. Chen, Sharon E. Jacob, Erin M. Warshaw, et al. “Long-term Efficacy of Topical Fluorouracil Cream, 5%, for Treating Actinic Keratosis: A Randomized Clinical Trial.” In Jama Dermatol, 151:952–60, 2015. https://doi.org/10.1001/jamadermatol.2015.0502.Full Text Link to Item
-
Winkelmayer, Wolfgang C., Aya A. Mitani, M Alan Brookhart, and Benjamin A. Goldstein. “FP663COMPARATIVE LONGER-TERM OUTCOMES OF IRON SUCROSE VERSUS SODIUM FERRIC GLUCONATE IN U.S. PATIENTS INITIATING HEMODIALYSIS. A PSEUDO-EXPERIMENTAL STUDY.” In Nephrology Dialysis Transplantation, 30:iii295–96. Oxford University Press (OUP), 2015. https://doi.org/10.1093/ndt/gfv182.11.Full Text
-
Dublin, Sascha, Michael Jackson, Tracey Marsh, Soko Setoguchi-Iwata, Wendy Camelo Castillo, and M Alan Brookhart. “New Approaches to Account for Selection Bias and Confounding by Frail Health Status.” In Pharmacoepidemiology and Drug Safety, 22:209–10. WILEY-BLACKWELL, 2013.Link to Item
-
Funk, Michele Jonsson, Daniel Westreich, Til Stuermer, and M Alan Brookhart. “Standard Errors & Confidence Limits for Doubly Robust Estimation.” In Pharmacoepidemiology and Drug Safety, 20:S1–2. WILEY-BLACKWELL, 2011.Link to Item
-
-
- Teaching & Mentoring
-
Recent Courses
Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.